MICHAEL PERRY - 10 Jan 2023 Form 4 Insider Report for ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

Role
Director
Signature
/s/Michael Perry
Issuer symbol
ARWR
Transactions as of
10 Jan 2023
Transactions value $
$0
Form type
4
Filing time
11 Jan 2023, 19:32:11 UTC
Previous filing
22 Nov 2022
Next filing
19 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARWR Common Stock Award $0 +7,867 +8.56% $0 99,767 10 Jan 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARWR Common Stock Award $0 +4,593 $0 4,593 10 Jan 2023 Common Stock 4,593 $33.03 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date.
F2 Represents options, which will vest in one installment on the first anniversary of the grant date.